Exact Mass: 469.19612420000004
Exact Mass Matches: 469.19612420000004
Found 146 metabolites which its exact mass value is equals to given mass value 469.19612420000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dactolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
His Asn Ala Glu
C18H27N7O8 (469.19210219999997)
Asn Ala His Glu
C18H27N7O8 (469.19210219999997)
Gln Ala His Asp
C18H27N7O8 (469.19210219999997)
Ala Asp His Gln
C18H27N7O8 (469.19210219999997)
Ala Asp Gln His
C18H27N7O8 (469.19210219999997)
Ala Glu His Asn
C18H27N7O8 (469.19210219999997)
Ala Glu Asn His
C18H27N7O8 (469.19210219999997)
Ala His Asp Gln
C18H27N7O8 (469.19210219999997)
Ala His Glu Asn
C18H27N7O8 (469.19210219999997)
Ala His Asn Glu
C18H27N7O8 (469.19210219999997)
Ala His Gln Asp
C18H27N7O8 (469.19210219999997)
Ala Asn Glu His
C18H27N7O8 (469.19210219999997)
Ala Asn His Glu
C18H27N7O8 (469.19210219999997)
Ala Gln Asp His
C18H27N7O8 (469.19210219999997)
Ala Gln His Asp
C18H27N7O8 (469.19210219999997)
Cys Gly Lys Tyr
C20H31N5O6S (469.19949460000004)
Cys Gly Tyr Lys
C20H31N5O6S (469.19949460000004)
Cys Lys Gly Tyr
C20H31N5O6S (469.19949460000004)
Cys Lys Tyr Gly
C20H31N5O6S (469.19949460000004)
Cys Tyr Gly Lys
C20H31N5O6S (469.19949460000004)
Cys Tyr Lys Gly
C20H31N5O6S (469.19949460000004)
Asp Ala His Gln
C18H27N7O8 (469.19210219999997)
Asp Ala Gln His
C18H27N7O8 (469.19210219999997)
Asp His Ala Gln
C18H27N7O8 (469.19210219999997)
Asp His Gln Ala
C18H27N7O8 (469.19210219999997)
Asp Gln Ala His
C18H27N7O8 (469.19210219999997)
Asp Gln His Ala
C18H27N7O8 (469.19210219999997)
Glu Ala His Asn
C18H27N7O8 (469.19210219999997)
Glu Ala Asn His
C18H27N7O8 (469.19210219999997)
Glu Gly His Gln
C18H27N7O8 (469.19210219999997)
Glu Gly Gln His
C18H27N7O8 (469.19210219999997)
Glu His Ala Asn
C18H27N7O8 (469.19210219999997)
Glu His Gly Gln
C18H27N7O8 (469.19210219999997)
Glu His Asn Ala
C18H27N7O8 (469.19210219999997)
Glu His Gln Gly
C18H27N7O8 (469.19210219999997)
Glu Asn Ala His
C18H27N7O8 (469.19210219999997)
Glu Asn His Ala
C18H27N7O8 (469.19210219999997)
Glu Gln Gly His
C18H27N7O8 (469.19210219999997)
Glu Gln His Gly
C18H27N7O8 (469.19210219999997)
Gly Cys Lys Tyr
C20H31N5O6S (469.19949460000004)
Gly Cys Tyr Lys
C20H31N5O6S (469.19949460000004)
Gly Glu His Gln
C18H27N7O8 (469.19210219999997)
Gly Glu Gln His
C18H27N7O8 (469.19210219999997)
Gly His Glu Gln
C18H27N7O8 (469.19210219999997)
Gly His Gln Glu
C18H27N7O8 (469.19210219999997)
Gly Lys Cys Tyr
C20H31N5O6S (469.19949460000004)
Gly Lys Tyr Cys
C20H31N5O6S (469.19949460000004)
Gly Gln Glu His
C18H27N7O8 (469.19210219999997)
Gly Gln His Glu
C18H27N7O8 (469.19210219999997)
Gly Tyr Cys Lys
C20H31N5O6S (469.19949460000004)
Gly Tyr Lys Cys
C20H31N5O6S (469.19949460000004)
His Ala Asp Gln
C18H27N7O8 (469.19210219999997)
His Ala Glu Asn
C18H27N7O8 (469.19210219999997)
His Ala Asn Glu
C18H27N7O8 (469.19210219999997)
His Ala Gln Asp
C18H27N7O8 (469.19210219999997)
His Asp Ala Gln
C18H27N7O8 (469.19210219999997)
His Asp Gln Ala
C18H27N7O8 (469.19210219999997)
His Glu Ala Asn
C18H27N7O8 (469.19210219999997)
His Glu Gly Gln
C18H27N7O8 (469.19210219999997)
His Glu Asn Ala
C18H27N7O8 (469.19210219999997)
His Glu Gln Gly
C18H27N7O8 (469.19210219999997)
His Gly Glu Gln
C18H27N7O8 (469.19210219999997)
His Gly Gln Glu
C18H27N7O8 (469.19210219999997)
His Asn Glu Ala
C18H27N7O8 (469.19210219999997)
His Gln Ala Asp
C18H27N7O8 (469.19210219999997)
His Gln Asp Ala
C18H27N7O8 (469.19210219999997)
His Gln Glu Gly
C18H27N7O8 (469.19210219999997)
His Gln Gly Glu
C18H27N7O8 (469.19210219999997)
Lys Cys Gly Tyr
C20H31N5O6S (469.19949460000004)
Lys Cys Tyr Gly
C20H31N5O6S (469.19949460000004)
Lys Gly Cys Tyr
C20H31N5O6S (469.19949460000004)
Lys Gly Tyr Cys
C20H31N5O6S (469.19949460000004)
Lys Tyr Cys Gly
C20H31N5O6S (469.19949460000004)
Lys Tyr Gly Cys
C20H31N5O6S (469.19949460000004)
Asn Ala Glu His
C18H27N7O8 (469.19210219999997)
Asn Glu Ala His
C18H27N7O8 (469.19210219999997)
Asn Glu His Ala
C18H27N7O8 (469.19210219999997)
Asn His Ala Glu
C18H27N7O8 (469.19210219999997)
Asn His Glu Ala
C18H27N7O8 (469.19210219999997)
Gln Ala Asp His
C18H27N7O8 (469.19210219999997)
Gln Asp Ala His
C18H27N7O8 (469.19210219999997)
Gln Asp His Ala
C18H27N7O8 (469.19210219999997)
Gln Glu Gly His
C18H27N7O8 (469.19210219999997)
Gln Glu His Gly
C18H27N7O8 (469.19210219999997)
Gln Gly Glu His
C18H27N7O8 (469.19210219999997)
Gln Gly His Glu
C18H27N7O8 (469.19210219999997)
Gln His Ala Asp
C18H27N7O8 (469.19210219999997)
Gln His Asp Ala
C18H27N7O8 (469.19210219999997)
Gln His Glu Gly
C18H27N7O8 (469.19210219999997)
Gln His Gly Glu
C18H27N7O8 (469.19210219999997)
Tyr Cys Gly Lys
C20H31N5O6S (469.19949460000004)
Tyr Cys Lys Gly
C20H31N5O6S (469.19949460000004)
Tyr Gly Cys Lys
C20H31N5O6S (469.19949460000004)
Tyr Gly Lys Cys
C20H31N5O6S (469.19949460000004)
Tyr Lys Cys Gly
C20H31N5O6S (469.19949460000004)
Tyr Lys Gly Cys
C20H31N5O6S (469.19949460000004)
NVP-BEZ235
dimenhydrinate
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Dimenhydrinate is an orally active H1-antihistamine consisting of Diphenhydramine (HY-B0303) and 8-Chlorotheophylline. Dimenhydrinate is used to prevent nausea, vomiting, dizziness, and vertigo associated with motion sickness[1].
Almotriptan
C21H31N3O7S (469.18826160000003)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Almotriptan Malate is a 5-HT1B/1D-receptor agonist used to treat migraine. IC50: Target: 5-hydroxytryptamine1B/1D (5-HT1B/1D) Receptor Almotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adults. Almotriptan showed low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors in several species, including the human, while affinity for 5-HT receptors other than 5-HT(1B/1D) was clearly less. Almotriptan did not exhibit significant affinity for several non-5-HT receptors studied up to 100 microM. Almotriptan inhibited forskolin-stimulated cyclic AMP accumulation in HeLa cells transfected with 5-HT(1B) or 5-HT(1D) human receptors [1]. Almotriptan had a mild antiemetic effect and a slight, transient diuretic effect in dogs, although the latter effect is probably of no clinical relevance. In addition, no effect on the respiratory system of conscious guinea pigs was observed following almotriptan treatment. These results indicate that almotriptan has a favourable safety profile with respect to the central nervous, renal and respiratory systems [2].
4H-1,2,4-Triazole, 3-(4-(3-(ethylsulfonyl)propyl)bicyclo(2.2.2)oct-1-yl)-4-methyl-5-(2-(trifluoromethyl)phenyl)-
C23H30F3N3O2S (469.20107160000003)
Mycophenolate mofetil hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
(2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-methoxypropyl)-1,4-benzoxazin-3-one
Dactolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[(2R,4aR,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
1-[(2R,3R,6R)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(3-chlorophenyl)urea
2-[(2S,4aR,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2R,4aS,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2S,4aR,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
1-[(2S,3R,6S)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(3-chlorophenyl)urea
1-[(2R,3S,6R)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-3-(3-chlorophenyl)urea
2-[(2R,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2S,4aS,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2S,4aR,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2R,4aR,12aR)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
N-[(2R,4aS,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
1-(3-chlorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
2-[(1R,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1R,3S,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1R,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1S,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(2S,4aS,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
2-[(2S,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
2-[(2R,4aS,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2S,4aS,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
(3S)-2-tert-butylsulfinyl-4-[3-[3-(dimethylamino)prop-1-ynyl]phenyl]-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid
C25H31N3O4S (469.20351660000006)
[(1R)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
1-(3-chlorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3-chlorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3-chlorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
1-(3-chlorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]urea
2-[(1S,3S,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1S,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1S,3S,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
2-[(1R,3S,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H28FN3O5 (469.20128900000003)
(3S)-4-[3-(1-cyclohexenyl)phenyl]-3-(2-hydroxyethyl)-N,N-dimethyl-2-methylsulfonyl-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C25H31N3O4S (469.20351660000006)
2-[(2R,4aS,12aR)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
2-[(2S,4aR,12aS)-8-(ethylsulfonylamino)-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-methoxyethyl)acetamide
C21H31N3O7S (469.18826160000003)
N-[(2R,4aR,12aS)-2-[2-(dimethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-fluorobenzamide
C25H28FN3O5 (469.20128900000003)
[(1S)-7-methoxy-2-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
[(1R)-7-methoxy-2-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
[(1S)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)
[(1S)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C25H31N3O4S (469.20351660000006)